Apnimed Inc. filed for a US initial public offering, as its oral drug to treat obstructive sleep apnea moves closer to being commercialized.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-07-10/shionogi-backed-apnimed-files-for-ipo-to-fund-sleep-apnea-drug)